David Darling, Ph.D. | Thought Leader | Pharma’s Almanac

Subscribe

Subscribe for the Newsletter

Mobile Navigation

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Market Research

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Community

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

Contact Us Advertise LinkedIn

My Account

Subscribe for the newsletter

© 2026 PHARMA'S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

David Darling, Ph.D.

Senior Principal Scientist, Innovation, ViroCell Biologics

1 Contributions1 / 1

1 / 1

De-Risking Cell and Gene Therapies with Innovative Solutions: A Review for Leveraging a Proven Workhorse Technology in New Ways

Viral Vectors

De-Risking Cell and Gene Therapies with Innovative Solutions: A Review for Leveraging a Proven Workhorse Technology in New Ways

Farzin Farzaneh, Ph.D.; Nicholas Ostrout, Ph.D.; Glenda Dickson, Ph.D.; David Darling, Ph.D.

ViroCell Biologics

PAO-06-25-CL-12Jul 31, 2025